Previous 10 | Next 10 |
Soligenix to Advance Synthetic Hypericin Development in Psoriasis - Validated clinical pharmacology and positive psoriasis proof-of-concept clinical study with synthetic hypericin sets stage for pipeline expansion - Plan to initiate follow-on Phase 2a clinical study in mild-...
Soligenix discusses its contribution to addressing future serious public health threats in a podcast New York, New York--(Newsfile Corp. - September 14, 2021) - PCG Digital -- The COVID-19 pandemic has already cost the United States an estimated $16 trillion in lost economic output , and has...
Soligenix (NASDAQ:SNGX) +26% FDA Grants soligenix orphan drug designation for the treatment of T-cell lymphoma Eloxx Pharmaceuticals (NASDAQ:ELOX) +22% announces fast track designation for ELX-02 for the treatment of cystic fibrosis patients with nonsense mutations Cardiff Oncology ...
FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma PR Newswire PRINCETON, N.J. , Sept. 9, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Solig...
Cellect Biotechnology (NASDAQ:APOP) +69% after reporting first ApoGraft Bone Marrow Transplantation in U.S. PagerDuty (NYSE:PD) +15% on Q2 earnings. Enveric Biosciences (NASDAQ:ENVB) +15%. MongoDB (NASDAQ:MDB) +14%. Sinopec Shanghai Petrochemical (NYSE:SHI) +13%. The OLB (NASDAQ:OLB...
Soligenix: Developing Tools to Tackle the Next Potential Pandemic; PCG Digital Biotech Watch Review PR Newswire NEW YORK , Aug. 24, 2021 /PRNewswire/ -- Vaccines are known for the stringent cold chain storage requirements necessary to maintain their integrity. In...
Soligenix Announces Publication Demonstrating Successful Formulation and Heat Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases Single-vial vaccine platform demonstrates high antibody levels against three lethal viruses PR Newswire ...
Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates - Potent efficacy data using purified antigens and CoVaccine HT™ adjuvant demonstrated in non-human primates (NHPs) published in Frontiers in Immunology - Thermostabil...
Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results PR Newswire PRINCETON, N.J. , Aug. 13, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developin...
New York, New York--(Newsfile Corp. - July 29, 2021) - -- PCG Digital -- Dr. Fauci said it publicly this week, but we've all been thinking it for months now. COVID-19 did not hit us, "out of the blue." Scientists, medical professionals, and researchers have been expecting this for years. The g...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView is pleased to announce an exclusive Q&A session with Dr. Ellen Kim, discussing the promising interim results of Soligenix's ( Nasdaq:SNGX ) HyBryte™ from the ongoing investigator-initiated study (IIS). HyBryte...